Biologist woman Aintzane Apraiz the 4-HPR studied in depth.

After previous research, this ability to rise to induce cell death. Applied applied this synthetic derivative to acute lymphoblastic leukemia T cells . Study in a leukemia model: defended her doctoral thesis at the University of the Basque Country , Role of sphingolipids and oxidative stress in antineoplasic activity of 4-HPR. Ms Apraiz also revealed that in the case of failure of treatment with 4-HPR, the possible effectiveness of alternative therapies are not affected. That is, the researchers observed that unlike what other treatments, the LLA -T cells that are resistant to 4-HPR sensitive sensitive based connections to other on and so alternative therapies for these latter compounds may well remain effective, although the 4-HPR has failed..

Ban praised the focus of Canada’s G8 initiative to improve maternal and child health, but he avoided a chance to offer a question from a viewer to Harper to criticize for not providing funds to maternal health programs that ,, according to the Canwest News Service / Calgary Herald . – On Wednesday, before a meeting with Canadian Prime Minister Stephen Harper, said UN Secretary-General Ban Ki-moon many topics in a speech warning that leaders of the G8 and G20 countries should not global economic and financial difficulties excuse to neglect previous pledges of billions of dollars for the world’s poor – for a doubling of aid to Africa, food security, malaria and AIDS programs and maternal and child health care, Canwest News Service / Calgary Herald writes (O’Neill..However not just no negative effect another as the routine post-operative pain, the volunteers said to vision in their eyes treated in the in poor lighting conditions. – reports the patient that light areas and perhaps some images but basically the message is that the treatment is totally safe, said William W. Hauswirth , a professor of Ophthalmologist and member UF Powell Gene Therapy Centre and that UF Genetic Institute. One of what we did not what we doing not do patient the immune system , which was done in two additional LCAs clinical studies going on under way, said Hauswirth, of the the study of the adeno-associated virus as vehicles to deliver genes started to providing to live animals exceeding 30 years ago.